Jorge Lima: Amniotic Fluid Embolism and Its Impact on Maternal and Perinatal Outcomes
Jorge Lima, Assistant Guest Professor at NOVA Medical School, Gynecologist and Obstetrician at Hospital da Luz Lisbon, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Obstetrical and Gynecological Survey, adding:
“I am pleased to share our latest article:
‘Amniotic Fluid Embolism: A Silent Threat to Maternal Life—An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.’
Published in Obstetrical and Gynecological Survey, one of the leading review journals in Obstetrics and Gynecology, this article provides an up-to-date overview of amniotic fluid embolism (AFE), one of the most devastating and unpredictable obstetric emergencies.
Together with Oluwateniayo O. Okpaise, João Feldman de Pinho, Edna Kathleen Porter, and Rodrigo Ruano, we review current evidence on:
- Epidemiology and risk factors;
- Pathophysiological and immunological mechanisms;
- Diagnostic challenges and emerging biomarkers;
- Contemporary management strategies;
- Maternal and neonatal outcomes.
Although rare, AFE remains associated with substantial maternal and perinatal morbidity and mortality.
Improving awareness, facilitating early diagnosis, and optimizing multidisciplinary management are essential to improving outcomes.
I am grateful to my co-authors for this rewarding international collaboration (UK ,USA and Portugal) and for their commitment to advancing knowledge in maternal-fetal medicine.”
Title: Amniotic Fluid Embolism: A Silent Threat to Maternal Life— An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome
Authors: Oluwateniayo O. Okpaise, Jorge Lima, João Feldman de Pinho, Edna Porter Kathleen, Rodrigo Ruano

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?